Known safety concerns, contraindications, and risk factors.
BPC-157 has extensive preclinical evidence but extremely limited human clinical data. Over 80% of published research originates from a single group. Exercise appropriate caution and source only from regulated compounding pharmacies.
Active Malignancy or Cancer History
BPC-157 stimulates angiogenesis — a pathway tumors exploit for growth and metastasis.
Pregnancy and Breastfeeding
Total absence of safety data for maternal or fetal health.
Von Hippel-Lindau Disease
Impact on angiogenic pathways is specifically contraindicated for this genetic condition.
Severe Cardiovascular Disease
Vascular remodeling effects require strict medical supervision.
Concurrent Psychiatric Medication
BPC-157 modulates serotonin, dopamine, and GABA systems — potential for clinically meaningful interactions with SSRIs, benzodiazepines, and antipsychotics.